Cargando…
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
BACKGROUND: There is no standard serum biomarker used for diagnosis or early detection of recurrence for renal cell carcinoma (RCC) patients. MicroRNAs (miRNAs) are abundant and highly stable in blood serum, and have been recently described as powerful circulating biomarkers in a wide range of solid...
Autores principales: | Redova, Martina, Poprach, Alexandr, Nekvindova, Jana, Iliev, Robert, Radova, Lenka, Lakomy, Radek, Svoboda, Marek, Vyzula, Rostislav, Slaby, Ondrej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340316/ https://www.ncbi.nlm.nih.gov/pubmed/22440013 http://dx.doi.org/10.1186/1479-5876-10-55 |
Ejemplares similares
-
miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: Merhautova, Jana, et al.
Publicado: (2015) -
Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma
por: Fedorko, Michal, et al.
Publicado: (2015) -
MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
por: Svoboda, Marek, et al.
Publicado: (2012) -
Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy
por: Slaby, Ondrej, et al.
Publicado: (2010) -
Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy
por: Slaby, Ondrej, et al.
Publicado: (2010)